Lazard Asset Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-205
| Closed | -$13K | – | 2247 |
|
2023
Q4 | $13K | Sell |
205
-1,288
| -86% | -$81.7K | ﹤0.01% | 2082 |
|
2023
Q3 | $111K | Buy |
1,493
+297
| +25% | +$22.1K | ﹤0.01% | 1594 |
|
2023
Q2 | $110K | Sell |
1,196
-6,874
| -85% | -$632K | ﹤0.01% | 1545 |
|
2023
Q1 | $836K | Buy |
8,070
+7,264
| +901% | +$753K | ﹤0.01% | 1039 |
|
2022
Q4 | $92K | Hold |
806
| – | – | ﹤0.01% | 1558 |
|
2022
Q3 | $87K | Buy |
806
+6
| +0.8% | +$648 | ﹤0.01% | 1528 |
|
2022
Q2 | $144K | Buy |
800
+210
| +36% | +$37.8K | ﹤0.01% | 1368 |
|
2022
Q1 | $100K | Sell |
590
-10,733
| -95% | -$1.82M | ﹤0.01% | 1397 |
|
2021
Q4 | $2.37M | Sell |
11,323
-4,524
| -29% | -$947K | ﹤0.01% | 905 |
|
2021
Q3 | $3.05M | Buy |
15,847
+2,486
| +19% | +$479K | ﹤0.01% | 855 |
|
2021
Q2 | $3.78M | Buy |
13,361
+7,203
| +117% | +$2.04M | ﹤0.01% | 762 |
|
2021
Q1 | $1.3M | Buy |
6,158
+5,588
| +980% | +$1.18M | ﹤0.01% | 862 |
|
2020
Q4 | $111K | Buy |
570
+29
| +5% | +$5.65K | ﹤0.01% | 1169 |
|
2020
Q3 | $88K | Sell |
541
-37,764
| -99% | -$6.14M | ﹤0.01% | 1042 |
|
2020
Q2 | $5.32M | Buy |
38,305
+37,284
| +3,652% | +$5.17M | 0.01% | 561 |
|
2020
Q1 | $63K | Buy |
1,021
+310
| +44% | +$19.1K | ﹤0.01% | 1109 |
|
2019
Q4 | $77K | Buy |
711
+466
| +190% | +$50.5K | ﹤0.01% | 988 |
|
2019
Q3 | $25K | Sell |
245
-11,684
| -98% | -$1.19M | ﹤0.01% | 1047 |
|
2019
Q2 | $1.53M | Sell |
11,929
-85
| -0.7% | -$10.9K | ﹤0.01% | 783 |
|
2019
Q1 | $1.53M | Buy |
12,014
+123
| +1% | +$15.7K | ﹤0.01% | 778 |
|
2018
Q4 | $1.49M | Sell |
11,891
-8,382
| -41% | -$1.05M | ﹤0.01% | 669 |
|
2018
Q3 | $4.49M | Hold |
20,273
| – | – | 0.01% | 587 |
|
2018
Q2 | $3.25M | Buy |
+20,273
| New | +$3.25M | 0.01% | 615 |
|